Healthcare
Tuesday, January 3, 2017
BRIEF-Kowa Pharmaceuticals enters agreement with CymaBay Therapeutics to license gout compound
* Kowa Pharmaceuticals America Inc announces agreement with
CymaBay Therapeutics to license gout compound
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment